Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma
Authors:
- Masanori YasudaMYMasanori Yasuda
- Michio ShimizuMSMichio Shimizu
- Masaki MiyazawaMMMasaki Miyazawa
- Shingo KamoshidaSKShingo Kamoshida
- Akiko UedaAUAkiko Ueda
- Ken TakataKTKen Takata
- Yuji SakumaYSYuji Sakuma
- Yohei MiyagiYMYohei Miyagi
- Yoichi KamedaYKYoichi Kameda
- 1 February 2010
- journal article
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 14 (1) , 23-29
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Therapeutic strategy targeting the mTOR–HIF‐1α–VEGF pathway in ovarian clear cell adenocarcinomaPathology International, 2008
- Hypoxia-Inducible Factor 1α in Clear Cell Renal Cell CarcinomaClinical Cancer Research, 2007
- Prognostic significance of HIF‐1α polymorphisms in transitional cell carcinoma of the bladderInternational Journal of Cancer, 2007
- Early squamous cell carcinoma of the oesophagus: the Japanese viewpointHistopathology, 2007
- Clinicopathologic significance of hypoxia-inducible factor 1α overexpression in gastric carcinomasJournal of Surgical Oncology, 2006
- Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel‐Lindau suppression and HIF1α activationInternational Journal of Cancer, 2006
- Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosisDiseases of the Esophagus, 2005
- HIF-1α mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinomaJournal of Cell Science, 2003
- Rho GTPase signalling pathways in the morphological changes associated with apoptosisCell Death & Differentiation, 2002
- Rac1 Activity Is Required for the Activation of Hypoxia-inducible Factor 1Journal of Biological Chemistry, 2001